Venlafaxine (Effexor): Uses, Side Effects, and Safety Guide

Dr. Sheridan Walter
Dr. Jennie Stanford
Written by Dr. Sheridan Walter on 06 August 2025
Medically reviewed by Dr. Jennie Stanford on 29 August 2025

Venlafaxine, sold under the brand name Effexor, is a serotonin-norepinephrine reuptake inhibitor (SNRI) prescribed for major depressive disorder and several anxiety disorders. It works by increasing the levels of serotonin and norepinephrine, two key neurotransmitters involved in mood regulation.

Key takeaways:
  • Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant for major depression and anxiety disorders, including generalized anxiety disorder, social anxiety disorder, and panic disorder.
  • Common side effects include nausea, dizziness, insomnia (or drowsiness), dry mouth, and sexual dysfunction. Venlafaxine can also raise blood pressure in some patients.
  • Venlafaxine carries a black box warning for increased suicidal thoughts in younger patients (like all antidepressants).
a close up photo of several brown venlafaxine (Effexor) capsules

What is venlafaxine (Effexor)?

Venlafaxine is an SNRI first approved by the FDA in 1993 for the treatment of major depressive disorder. It is available in immediate-release (IR) and extended-release (Effexor XR) forms. It is thought to work by increasing the levels of mood-enhancing chemicals called serotonin and norepinephrine in the brain.

Medical uses of venlafaxine

Venlafaxine is FDA-approved to treat the following conditions in adults:

  • Major depressive disorder (MDD)
  • Generalized anxiety disorder (GAD)
  • Social anxiety disorder
  • Panic disorder

Off-label uses of Effexor include:

  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder (OCD)
  • Certain types of chronic neuropathic pain (diabetic neuropathy or fibromyalgia)
  • Migraine prevention
  • Menopausal hot flashes

These off-label uses should, however, be guided by evidence and utilized under close medical supervision.

How venlafaxine works

Venlafaxine increases the activity of key neurotransmitters by inhibiting the reuptake of serotonin and norepinephrine in the brain. Put differently, it prevents nerve cells from reabsorbing these neurotransmitters, making more serotonin and norepinephrine available to improve communication between neurons.

At lower doses, venlafaxine mostly affects serotonin. As the dose increases, it also affects norepinephrine, which may make it more effective for some people.

Dosage guidelines

For adults with depression or anxiety, a typical starting dose is 75 mg per day (either 75 mg once daily of the extended-release formulation or 37.5 mg twice daily of the immediate-release formulation of Effexor). In some cases (especially for anxiety), doctors may start at 37.5 mg per day to minimize any possible side effects and then increase the dose gradually.

Titration

The dose is increased every few days based on the patient’s response. The usual effective dose range is 75–225 mg daily. If necessary, the dose may be increased to a maximum of 225 mg/day for extended-release (or 375 mg per day in divided doses for immediate-release).

Administration

Venlafaxine should be taken with food to reduce stomach upset. Extended-release capsules must be swallowed whole (not crushed or opened). If a dose is missed, take it as soon as possible unless it’s almost time for the next dose (do not double up doses).

Potential side effects

Common side effects of Effexor include:

  • Nausea
  • Dizziness
  • Insomnia
  • Drowsiness
  • Dry mouth
  • Sexual side effects (such as reduced libido or delayed orgasm)
  • High blood pressure

These effects are usually tolerable and improve within the first couple of weeks. Taking venlafaxine with food can reduce nausea. If it leads to insomnia, morning dosing may help. For drowsiness, evening dosing may be more appropriate.

More rare serious effects of venlafaxine include:

Overall, most side effects are manageable. Patients are advised to report any severe or persistent adverse effects to their healthcare provider immediately.

Safety considerations and contraindications

Antidepressants (like venlafaxine) may increase suicidal thoughts in adolescents and young adults during the first few weeks of treatment. It’s essential that doses are closely monitored, especially in the early stages, when mood changes can be unpredictable.

Contraindication

Do not take venlafaxine if you are currently on or have recently (within 2 weeks) taken a monoamine oxidase inhibitor (MAOI). Combining an SNRI with an MAOI can cause a dangerous increase in serotonin in the brain, leading to serotonin syndrome, as previously mentioned. Also, don't take venlafaxine if you have had a severe allergic reaction to venlafaxine or its active metabolite (desvenlafaxine).

Cautions

Use extra caution if you have uncontrolled high blood pressure, heart disease, epilepsy, bipolar disorder, or narrow-angle glaucoma. Doctors advise that venlafaxine should be avoided in pregnancy and breastfeeding unless absolutely necessary. Talk to your doctor about your options if you are pregnant, planning to become pregnant, or breastfeeding.

Drug interactions

Combining venlafaxine with other medications that have effects on serotonin, such as other antidepressants (like selective serotonin reuptake inhibitors or SSRIs), certain migraine drugs like triptans, or the supplement St. John’s Wort, can increase the risk of serotonin syndrome.  Combining alcohol or sedative drugs with Effexor can enhance the effects of drowsiness and dizziness.

Venlafaxine withdrawal and discontinuation syndrome

Sudden discontinuation of venlafaxine can cause withdrawal symptoms, also known as antidepressant discontinuation syndrome. Because venlafaxine leaves the body quickly, missing even one dose can sometimes trigger uncomfortable withdrawal symptoms.

Symptoms of venlafaxine withdrawal may include:

  • Dizziness
  • Headaches
  • Nausea
  • Flu-like body aches
  • Insomnia with vivid dreams
  • “Electric shock” sensations or “brain zaps”
  • Irritability
  • Anxiety

While not usually dangerous, these symptoms can feel intense and overwhelming. It’s important to know they’re temporary. Abruptly stopping venlafaxine can increase the risk of withdrawal syndrome, which is often more intense than with SSRI antidepressants. To avoid this, doctors recommend gradually reducing the dose when discontinuing venlafaxine.  

Venlafaxine overdose

An overdose of venlafaxine is a medical emergency. Taking a much higher-than-prescribed dose can lead to serious toxicity. Symptoms of overdose include:

  • Extreme drowsiness
  • Rapid heartbeat
  • Low blood pressure
  • Severe nausea/vomiting
  • Seizures
  • Signs of serotonin syndrome (agitation, fever, and tremors)
  • Heart rhythm disturbances (arrhythmia)

Statistics show that venlafaxine is more toxic in overdose than many other antidepressant medications, with potential toxicity comparable to that of older tricyclic antidepressants. Getting immediate hospital care greatly improves the chances of recovery.

Misuse and addiction potential

Venlafaxine is not considered addictive. It’s not a controlled substance and does not produce a “high” or cravings, making its abuse potential low. While a person’s body can become dependent on venlafaxine (meaning withdrawal symptoms will occur if stopped abruptly), this is a physical dependence due to the medication’s effect on the body, not a compulsive addiction.

There have been a few rare documented cases of venlafaxine misuse at high doses, typically in people with a history of substance use disorder. Such occurrences are unusual and not representative of how the medication is generally used. When taken as prescribed under medical supervision, venlafaxine has a minimal risk of misuse or addiction.

Treatment and when to seek help

Be vigilant and seek medical advice or help in certain situations while on venlafaxine:

  • Emergency symptoms: If you experience severe symptoms such as high fever, confusion, or muscle rigidity
  • Worsening mood: For any new or worsening psychological symptoms (such as thoughts about suicide)
  • Overdose: In the event of an overdose (or suspected overdose)
  • Pregnancy: If you become pregnant while taking venlafaxine
  • Taking too much: In the rare occurrence, if you find yourself taking too much of Effexor

Always follow your doctor’s guidance. Never adjust the dose or stop the medication on your own—doing so can be risky due to withdrawal effects and the return of unwanted symptoms (including suicidal thoughts in extreme cases). If you have any concerns or side effects, it’s important to consult with your healthcare provider, who can adjust the treatment plan or provide supportive measures.

FAQs

Common questions about venlafaxine

How strong is venlafaxine compared to other antidepressants?

Some research suggests venlafaxine may be slightly more effective than SSRIs for treating major depression. Its dual serotonin-norepinephrine reuptake mechanism can benefit certain patients. However, its overall efficacy is comparable to other modern antidepressants, and each person’s response varies. One person might do better on an SSRI, whereas another may have better results on venlafaxine. Thus, venlafaxine is a powerful antidepressant option, but it is not necessarily stronger than other antidepressants.

Is venlafaxine a high-risk medication?

When used appropriately with medical supervision, venlafaxine is safe and effective; however, it should be used responsibly and with regular check-ins with your doctor.

How long does it take to work?

Venlafaxine does not work immediately. Most people start to notice some improvement after 1–2 weeks (for example, better sleep, slightly reduced anxiety, and more energy), but the full antidepressant effect usually takes 4–6 weeks of daily use. It’s important to keep taking it as prescribed, even if you don’t feel much change in the first couple of weeks.

How long is it safe to take venlafaxine?

There is no strict time limit. Venlafaxine is generally safe to take long-term if needed. Many people use it for months or years to manage depression or anxiety. Doctors will periodically reassess if you still need the medication, but if it continues to help and side effects are manageable, you can stay on venlafaxine for as long as needed. When it’s time to stop, the dose should be tapered slowly to minimize withdrawal effects (especially after long-term use).

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Shelton R. C. (2019). Serotonin and Norepinephrine Reuptake Inhibitors. Handbook of experimental pharmacology, 250, 145–180.
  2. Katzman, M. A., & Jacobs, L. (2007). Venlafaxine in the treatment of panic disorder. Neuropsychiatric disease and treatment, 3(1), 59–67.
  3. National Alliance on Mental Illness. (n.d.). Venlafaxine (Effexor). In About mental illness: Treatments – Mental health medications. Retrieved June 16, 2025 from
  4. Sansone, R. A., & Sansone, L. A. (2014). Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innovations in clinical neuroscience, 11(3-4), 37–42.
  5. Harvey, A. T., Rudolph, R. L., & Preskorn, S. H. (2000). Evidence of the dual mechanisms of action of venlafaxine. Archives of general psychiatry, 57(5), 503–509.
  6. Medsafe. (2024, June 11). Efexor-XR (venlafaxine hydrochloride) modified release capsules: Data sheet [PDF]. New Zealand Ministry of Health. Retrieved from
  7. National Health Service. (2022, February 10). Venlafaxine: How and when to take venlafaxine. In NHS Medicines A to Z. Retrieved June 16, 2025 from
  8. Electronic Medicines Compendium. (2025, February). Venlafaxine 37.5 mg and 75 mg tablets: Package leaflet [PDF]. Retrieved June 16, 2025 from
  9. Pfizer Inc. (2023, October). Effexor XR (venlafaxine hydrochloride extended-release capsules): Prescribing information[PDF]. Retrieved June 16, 2025 from
  10. RXList. (2023). Effexor XR (venlafaxine hydrochloride extended-release). Retrieved June 16, 2025 from
  11. Wyeth Pharmaceuticals Inc. (2017, January). Effexor XR (venlafaxine hydrochloride extended-release) capsules: Prescribing information [PDF]. U.S. Food and Drug Administration. Retrieved June 16, 2025 from
  12. Yates, S. J., Ahuja, N., Gartside, S. E., & McAllister-Williams, R. H. (2011). Serotonin Syndrome following Introduction of Venlafaxine following Withdrawal of Phenelzine: Implications for Drug Washout Periods. Therapeutic advances in psychopharmacology, 1(4), 125–127.
  13. Mothertobaby. (2023). Venlafaxine (Effexor®): Pregnancy and breast-feeding. In Medications and pregnancy. U.S. National Library of Medicine. Retrieved June 16, 2025 from
  14. Sabljić, V., Ružić, K., & Rakun, R. (2011). Venlafaxine withdrawal syndrome. Psychiatria Danubina, 23(1), 117–119.
  15. Whyte, I. M., Dawson, A. H., & Buckley, N. A. (2003). Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM: An International Journal of Medicine, 96(5), 369-374.
  16. National Health Service. (2025). Common questions about venlafaxine. In NHS Medicines A to Z. Retrieved June 16, 2025 from
  17. Eşsizoğlu, A., Yaşan, A., Bülbül, İ., Karabulut, E., & Gürgen, F. (2012). Venlafaxine addiction without a history of alcohol and substance abuse: A case report. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences, 25(4), 376–378. Retrieved from

Activity History - Last updated: 29 August 2025, Published date:


Reviewer

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Jennie Stanford, MD, FAAFP, DipABOM is a dual board-certified physician in both family medicine and obesity medicine. She has a wide range of clinical experiences, ranging from years of traditional clinic practice to hospitalist care to performing peer quality review to ensure optimal patient care.

Activity History - Medically Reviewed on 04 August 2025 and last checked on 29 August 2025

Medically reviewed by
Dr. Jennie Stanford

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

Related topics

Depression

7 minutes read

Anxiety Disorders

11 minutes read